• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G125
Device Problems Pacing Problem (1439); Inaccurate Synchronization (1609); Unexpected Therapeutic Results (1631)
Patient Problems Ventricular Fibrillation (2130); Electric Shock (2554); Syncope/Fainting (4411)
Event Date 02/13/2022
Event Type  Injury  
Manufacturer Narrative
This investigation will be updated should further pertinent information be provided.
 
Event Description
It was reported that the patient passed out while driving.The patient was experiencing an atrial fibrillation (af) with rapid ventricular response for which inappropriate anti-tachycardia pacing (atp) was received.Then at one of the episodes, atp was delivered and a ventricular fibrillation (vf) was developed.The device received various shocks to terminate the rhythm.The first two electric shocks were ineffective but the last one converted the rhythm.The patient was brought to the clinic were the cardiac resynchronization therapy defibrillator (crt-d) was adjusted and the patient was put on anti-arrhythmic drugs.The patient was hospitalized for several days.The patient was told the crt-d was programmed incorrectly.The crt-d remains in service at this time.No additional adverse patient effects were reported.
 
Event Description
It was reported that the patient passed out while driving.The patient was experiencing an atrial fibrillation (af) with rapid ventricular response for which inappropriate anti-tachycardia pacing (atp) was received.Then at one of the episodes, atp was delivered and a ventricular fibrillation (vf) was developed.The device received various shocks to terminate the rhythm.The first two electric shocks were ineffective but the last one converted the rhythm.The patient was brought to the clinic were the cardiac resynchronization therapy defibrillator (crt-d) was adjusted and the patient was put on anti-arrhythmic drugs.The patient was hospitalized for several days.The patient was told the crt-d was programmed incorrectly.No additional adverse patient effects were reported.This crt-d remained in service until the patient passed away due to reasons unrelated to this crt-d.The device was explanted and returned for analysis.
 
Manufacturer Narrative
This investigation will be updated should further pertinent information be provided.The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key14570431
MDR Text Key293137952
Report Number2124215-2022-19221
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589126
UDI-Public00802526589126
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/01/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/10/2022
Device Model NumberG125
Device Catalogue NumberG125
Device Lot Number138606
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/10/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/19/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age76 YR
Patient SexFemale
-
-